Analysis: Little to fear for Fresenius in U.S. health spending cuts

FRANKFURT (Reuters) – Fresenius Medical Care's focus on a life-threatening illness and its buying power with suppliers mean the world's biggest kidney dialysis provider may cope better with cuts in U.S. healthcare spending than many investors think. FMC's shares have slumped about 10 percent over the past three months on expectation the United States, battling to rein in its budget deficit, will reduce funds for state-run health schemes like Medicare that account for about 30 percent of the German company's revenues. …